Live News EQUITY FLASH M impact Nov 17, 2026, 09:43 PM UTC Merck Stops Blood Cancer Drug Trials After Risk Assessment Merck has stopped trials of a blood cancer drug following a risk assessment. MRK SquawkNews Desk